January/February 2022

Column

Trending From ACCC

Registration Opens for the ACCC 48th Annual Meeting and Cancer Center Business Summit

02/16/2022

Association of Community Cancer Centers

Authors from ACCC outline their upcoming 48th Annual Meeting and Cancer Center Business Summit, which will include a panel on how cancer programs and practices are using their data, a keynote titled, "(Over)-Paying for Cancer Care," and more.

Authors from ACCC outline their...

02/16/2022

Journal of Clinical Pathways

Editor's Page

A Call to Action

02/15/2022

Winston Wong, PharmD, Editor-in-Chief

Winston Wong, PharmD, Editor-in-Chief discusses the scope of Journal of Clinical Pathway's growth since its establishment in 2015, calling on a need to also expand the expertise of the Journal's peer reviewers.

Winston Wong, PharmD,...

02/15/2022

Journal of Clinical Pathways

Clinical Pathways GPS

Improving Diabetic Management in Long-term Care

02/15/2022

Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor

Richard G Stefanacci, DO, MGH, MBA, and colleagues discuss how clinical pathways can improve the Quadruple Aim for the management of diabetes in long-term care.

Richard G Stefanacci, DO, MGH,...

02/15/2022

Journal of Clinical Pathways

Pharma Insights

Bringing Social Determinants of Health to Life to Optimize Health Outcomes in Patients With Chronic Conditions

02/15/2022

Elizabeth Oyekan, PharmD, FCSHP, CPHQ

Maureen Hennessey, PhD, CPCC, CPHQ

Dominic Galante, MD, MS

Cynthia Miller, MD, MPH, FACP

Jorge Font, MPH

Elizabeth Oyekan, PharmD, FCSHP, CPHQ, and colleagues address health care disparities in patients with chronic conditions, the roles of health systems and payers in closing these gaps, and a customizable SDOH toolbox to help stakeholders...

Elizabeth Oyekan, PharmD, FCSHP,...

02/15/2022

Journal of Clinical Pathways

Department

Conferences

Metastatic Breast Cancer Updates From the 2021 San Antonio Breast Cancer Symposium

02/15/2022

J Clin Pathways. 2022;8(1):26-27. December 7-10, 2021; San Antonio, Texas and Virtual.

J Clin Pathways....

02/15/2022

Journal of Clinical Pathways

Research in Review

Highlights from the 63rd American Society of Hematology (ASH) Annual Meeting

02/15/2022

JCP Editors

02/15/2022

Journal of Clinical Pathways

Feature

From the Field

Streamlining Institutional Pathway Processes: The Development and Implementation of a Pathology Molecular Consult to Facilitate Convenient and Efficient Ordering, Fulfillment, and Reporting for Tissue Molecular Tests

02/15/2022

Daniel Mettman, MD

Michael Goodman, MD

Joseph Modzelewski

Linda Verkruyse, MD

Susie Willis

Janet Barrett

Robert Hoyt, MD

Maryam Abdo, MBChB

Hanan Elsarraj, MD

Sharad Mathur, MD

Daniel Mettman, MD, and colleagues detail the work of two mid-sized VA medical centers in collectively developing and implementing a consult process as part of their oncology clinical pathways to standardize ordering, fulfillment, and...

Daniel Mettman, MD, and...

02/15/2022

Journal of Clinical Pathways

Research Reports

Factors Associated With Poor Outcomes in Patients who Receive Cancer Directed Therapy at the End of Life

02/15/2022

Yasmine Anouty, PharmD

Ila M. Saunders, PharmD, BCOP

Shanna Block, PharmD, BCOP

Katherine Medley, PharmD

Rabia S. Atayee, PharmD, BCPS

Megan Wall, MS

Alison Wall, MS

Carolyn Mulroney, MD

Janine Martino, PharmD, BCOP, APh

Yasmine Anouty, PharmD, and colleagues discern factors that may be associated with poor outcomes in adult patients who received intravenous cancer-directed therapy in the last 30 days of life.

Yasmine Anouty, PharmD, and...

02/15/2022

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Editorial Correspondence

January/February 2022

Column

Department

Feature

Current Issue

Special Reports

Subscribe

February 2022 Volume 8 Issue 1

Specialties

Events

Year Round Education

HMP Global Products